The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
Twenty-seven of 152 patients (18%) with progressing hormone resistant prostate cancer had normal serum levels of prostate specific antigen (PSA less than or equal to 10 micrograms l-1), when referred for secondary treatment. PSA was significantly correlated with the extent of skeletal metastases (R:...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1992
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977889/ |